Angerer, V; Mogler, L; Steitz, J; Bisel, P; Hess, C; Schoeder, CT; Müller, CE; Huppertz, LM; Westphal, F; Schäper, J; Auwärter, V. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE. Drug Test. Anal., 1 Mar 2018, 10 (3), 597-603. 511 kB. https://doi.org/10.1002/dta.2237
Longworth, M; Banister, SD; Boyd, R; Kevin, RC; Connor, M; McGregor, IS; Kassiou, M. The pharmacology of cumyl-carboxamide synthetic cannabinoid new psychoactive substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and their analogues. ACS Chem. Neurosci., 9 Aug 2017, 8 (10), 2159-2167. 1.7 MB. https://doi.org/10.1021/acschemneuro.7b00267 #9
Asada, A; Doi, T; Tagami, T; Takeda, A; Satsuki, Y; Kawaguchi, M; Nakamura, A; Sawabe, Y. Cannabimimetic activities of cumyl carboxamide-type synthetic cannabinoids. Forensic Toxicol., 1 Jan 2018, 36 (1), 170-177. 585 kB. https://doi.org/10.1007/s11419-017-0374-9 #3
EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
Hess, C; Murach, J; Krueger, L; Scharrenbroch, L; Unger, M; Madea, B; Sydow, K. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples. Drug Test. Anal., 1 May 2017, 9 (5), 721-733. 267 kB. https://doi.org/10.1002/dta.2030 #Cumyl Pica LC,MS
Abbate, V; Schwenk, M; Presley, BC; Uchiyama, N. The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report). Pure Appl. Chem., 28 Aug 2018, 90 (8), 1255–1282. 1.0 MB. https://doi.org/10.1515/pac-2017-0605 #7. CUMYL-PICA
Banister, SD; Connor, M. The chemistry and pharmacology of synthetic cannabinoid receptor agonist new psychoactive substances: Evolution. In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 191-226. 1.2 MB. https://doi.org/10.1007/164_2018_144 #80
Alam, RM; Keating, JJ. Adding more “spice” to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists. Drug Test. Anal., 1 Mar 2020, 12 (3), 297–315. 2.8 MB. https://doi.org/10.1002/dta.2752 #75 Structure 71 has a single bond where a double bond belongs
Halter, S; Pulver, B; Wilde, M; Haschimi, B; Westphal, F; Riedel, J; Pütz, M; Schönberger, T; Stoll, S; Schäper, J; Auwärter, V. Cumyl‐CBMICA: A new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain. Drug Test. Anal., 23 Oct 2020, 13 (1), 208-216. 1.3 MB. https://doi.org/10.1002/dta.2942 #Cumyl-PICA MS,NMR,IR,other
Ametovski, A; Macdonald, C; Manning, JJ; Haneef, SAS; Santiago, M; Martin, L; Sparkes, E; Reckers, A; Gerona, RR; Connor, M; Glass, M; Banister, SD. Exploring stereochemical and conformational requirements at cannabinoid receptors for synthetic cannabinoids related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA. ACS Chemical Neuroscience, 4 Nov 2020, 11 (21), 3672–3682. 3.5 MB. https://doi.org/10.1021/acschemneuro.0c00591 #6 MS,NMR